SQUAMOUS CELL CARCINOMA
Clinical trials for SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Zapping skin cancer: laser and cream combo aims to replace surgery
Disease control Recruiting nowThis study is testing a non-surgical treatment for common skin cancers like basal cell and squamous cell carcinoma. Researchers are using fractional lasers on the cancer spots, followed by a prescription ointment applied for five nights. The goal is to effectively treat the cance…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Bruce Robinson, MD • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New Two-Pronged attack on mouth cancer shows promise
Disease control Recruiting nowThis study is testing whether adding two immunotherapy drugs (tiragolumab and atezolizumab) before and after standard surgery and chemoradiation can better control advanced oral cavity cancer. It is for adults newly diagnosed with a specific type of tumor (PD-L1 positive) that is…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New Virus-Based cancer injection enters human testing
Disease control Recruiting nowThis early-stage study is testing the safety and early effectiveness of an experimental cancer treatment called T3011. The treatment is injected directly into tumors and is being tested both alone and combined with an existing immunotherapy drug (pembrolizumab) in people with adv…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: ImmVira Pharma Co. Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New combo treatment aims to boost sinus cancer fight
Disease control Recruiting nowThis study is testing whether adding an immunotherapy drug (pembrolizumab) to standard chemotherapy and radiation improves outcomes for people with advanced squamous cell cancer in the nasal cavity or sinuses. The goal is to increase the number of patients whose tumors shrink sig…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug combo aims to spare cancer patients from disfiguring surgery
Disease control Recruiting nowThis study is testing a new approach for people with advanced head and neck cancer. The goal is to see if giving a combination of chemotherapy and immunotherapy *before* surgery can shrink tumors enough to allow surgeons to perform less extensive operations. This could help prese…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New pill tested to fight aggressive brain cancers
Disease control Recruiting nowThis study is testing a new oral medication called NEO212 for adults with specific aggressive brain tumors (like glioblastoma) or brain metastases from other cancers. The main goals are to find a safe and effective dose, see how the body processes the drug, and check if it can he…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Doctors train Patients' own cells to fight lung cancer in new trial
Disease control Recruiting nowThis study is testing a personalized cell therapy for adults with advanced non-small cell lung cancer that has stopped responding to standard treatments. Doctors remove a patient's tumor, grow special immune cells from it in a lab, and then infuse a large number of these 'tumor-f…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New cancer drug offered to patients through special access program
Disease control AVAILABLEThis program provides access to an experimental drug called AVM0703 for patients with various solid tumors and blood cancers. It is for people who may not have other treatment options. The drug aims to help the body's immune system fight cancer, and early reports show mostly mild…
Matched conditions: SQUAMOUS CELL CARCINOMA
Sponsor: AVM Biotechnology Inc • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New drug trial offers hope for Tough-to-Treat skin cancer
Disease control Recruiting nowThis study is testing whether the drug afatinib can help control advanced skin cancer that can't be treated with surgery or radiation. It's for people whose cancer has continued to grow despite trying immunotherapy. Researchers will measure if tumors shrink, how long the cancer s…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Glowing dye in surgery could stop dangerous throat leaks
Disease control Recruiting nowThis study is testing if a special imaging technique used during throat surgery can reduce a common and serious complication called a pharyngocutaneous fistula (a leak in the throat). During surgery, doctors will inject a safe dye and use a special camera to see which throat tiss…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Matthew Spector • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Italian researchers develop advanced cancer testing system
Diagnosis Recruiting nowThis study is testing a new diagnostic platform called IT-TCP that analyzes tumor samples from patients with high-risk cancers. Researchers will collect samples from 300 patients with various cancers including leukemia, pancreatic cancer, and melanoma to see if this detailed anal…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Azienda Ospedaliero-Universitaria di Parma • Aim: Diagnosis
Last updated Apr 01, 2026 14:41 UTC
-
Cancer care comes home: study tests if home treatment beats clinic visits
Symptom relief Recruiting nowThis study is testing whether cancer patients prefer to receive their standard drug treatments at home instead of in a clinic. Researchers want to see if home-based care reduces the burden of travel and improves treatment satisfaction and quality of life for patients. A specializ…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC
-
Cancer patients choose: quick shot or IV drip?
Symptom relief Recruiting nowThis study asks cancer patients which way they prefer to receive their immunotherapy drugs: as a quick injection under the skin or through a longer IV infusion. Researchers will enroll 480 people with various advanced cancers to compare comfort, convenience, and quality of life b…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Symptom relief
Last updated Mar 30, 2026 14:31 UTC
-
Researchers investigate hidden cancer risk in HIV-Prevention group
Knowledge-focused Recruiting nowThis study aims to understand anal cancer risk in men who have sex with men (MSM) who take medication to prevent HIV. Researchers want to know how common precancerous changes are in this group and test different screening methods to detect them early. The study will also measure …
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Scientists probe the source of oral cancer pain
Knowledge-focused Recruiting nowThis study aims to understand why oral cancer causes pain from pressure and stretching, like when talking or swallowing. Researchers will compare pain sensitivity in 40 oral cancer patients and 40 healthy volunteers. The goal is to gather knowledge that could lead to new pain tre…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: New York University • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Massive 12,000-Patient study aims to unlock secrets of lung cancer survival
Knowledge-focused Recruiting nowThis study aims to collect detailed information on 12,000 patients with lung and other chest cancers over many years. By tracking their treatments, health, and quality of life, researchers hope to understand why outcomes vary so much between patients. The goal is to use this real…
Matched conditions: SQUAMOUS CELL CARCINOMA
Sponsor: Dutch Society of Physicians for Pulmonology and Tuberculosis • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC